| Autor: |
Babbedge, R C, Hart, S L, Moore, P K |
| Zdroj: |
Journal of Pharmacy and Pharmacology; January 1993, Vol. 45 Issue: 1 p77-79, 3p |
| Abstrakt: |
The anti-nociceptive effect of selective inhibitors of nitric oxide synthase has been assessed in a formalin-induced paw-licking model in mice. l-NG-Nitro arginine methyl ester (l-NAME) but not l-NG-monomethyl arginine (l-NMMA) exhibited anti-nociceptive activity in both the early and late phases of paw licking following intraperitoneal administration. The effect on the late phase response was more pronounced. l-NAME (0·1–100 μg) and l-NG-nitro arginine base (l-NOARG; 10 μg) but not d-NAME (10 μg) were also anti-nociceptive following intracerebroventricular administration. l-NAME (10 μg) administered by this route did not influence locomotor activity. l-NMMA was inactive at doses up to 40 μg by this route. At higher doses (75–200 μg) l-NMMA produced a similar and non-dose related reduction in early/late phase paw-licking time. d-NMMA (100 μg) was inactive. The greater anti-nociceptive effect of l-NAME in this model accords with recently published biochemical data indicating that l-NAME is several orders of magnitude more potent than l-NMMA as an inhibitor of brain nitric oxide synthase. These data support the use of l-NAME as a selective tool to investigate the central pharmacological effects of nitric oxide. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Plný text